Kaya Limited Q4 FY26 results press release summary

Results press release of 20 May 2026, summarised by AI from the filing.

Kaya Q4 FY26 standalone revenue ₹55.8 cr, up 2%, PAT ₹(27.1) cr after ₹11.8 cr impairment; clinic revenue up 7%.

Key takeaways

1. Clinic growth Clinic business revenue grew 7% over Q4 FY25.
2. Standalone revenue ₹55.8 cr for Q4 FY26, a growth of 2% over Q4 FY25.
3. Acne & Scars Grew 52% over Q4 FY25, aided by new service technology.
4. Product business Grew 21% over Q4 FY25, driven by Nutraceutical, Lighter and Brighter and Anti-Aging.

Original filing on BSE

Kaya Limited Q1 FY27 results

As filed: Revenue ₹60.1 cr (+13% year on year), EBITDA ₹3.9 cr (+29% year on year), PAT −₹15.2 cr, EBITDA margin 6.4% (+76 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹55.8 cr (+1% year on year), EBITDA −₹12.7 cr (−300% year on year), PAT −₹27.8 cr, EBITDA margin -22.7% (−1,000 bps). Score 15 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was well below it. EBITDA margin fell 1000 bps year on year. Revenue fell 7% from last quarter. Share price after the results: +2.0% in 30 days (Nifty 500: +2.8%).
• Q3 FY26: Revenue ₹60.0 cr (+4% year on year), EBITDA −₹11.5 cr (−291% year on year), PAT −₹35.6 cr, EBITDA margin -19.1% (−1,000 bps). Score 15 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was well below it. EBITDA margin fell 1000 bps year on year. Share price after the results: −10.7% in 30 days (Nifty 500: +1.5%).
• Q2 FY26: Revenue ₹54.0 cr (+2% year on year), EBITDA −₹3.0 cr (−160% year on year), PAT −₹19.0 cr, EBITDA margin -5.6% (−1,000 bps). Score 15 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it. EBITDA margin fell 1000 bps year on year. Share price after the results: −15.5% in 29 days (Nifty 500: −0.5%).
• Q1 FY26: Revenue ₹53.0 cr (−13% year on year), EBITDA ₹3.0 cr, PAT −₹14.0 cr (−114% year on year), EBITDA margin 5.7% (+894 bps). Score 20 of 100, Below trend. Revenue growth was below the company's own trend. EBITDA margin rose 894 bps year on year. Revenue fell 4% from last quarter. Share price after the results: −3.5% in 30 days (Nifty 500: +0.1%).
• Q4 FY25: Revenue ₹55.0 cr (−43% year on year), EBITDA ₹2.0 cr, PAT −₹7.0 cr, EBITDA margin 3.6% (+1,000 bps). Score 36 of 100, Below trend. Revenue growth was well below the company's own trend. EBITDA margin rose 1000 bps year on year. Revenue fell 5% from last quarter. Share price after the results: +22.1% in 30 days (Nifty 500: +3.7%).
• Q3 FY25: Revenue ₹58.0 cr (−43% year on year), EBITDA ₹6.0 cr (−54% year on year), PAT ₹4.0 cr, EBITDA margin 10.3% (−240 bps). Score 28 of 100, Below trend. Revenue growth was well below the company's own trend. EBITDA margin fell 240 bps year on year.
• Q2 FY25: Revenue ₹53.0 cr (−48% year on year), EBITDA ₹5.0 cr (−58% year on year), PAT −₹16.0 cr, EBITDA margin 9.4% (−245 bps). Score 3 of 100, Below trend. EBITDA margin fell 245 bps year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 13% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Kaya Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Results press release (3 Aug 2026)
• Q4 FY26: Results press release (20 May 2026)
• Q2 FY26: Results press release (13 Nov 2025)